Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression

por Cloud, Ashley S., Vargheese, Aditya M., Gunewardena, Sumedha, Shimak, Raeann M., Ganeshkumar, Sornakala, Kumaraswamy, Easwari, Jensen, Roy A., Chennathukuzhi, Vargheese M.
Publicado 2022

Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis

por Cloud, Ashley S., Koohestani, Faezeh, McWilliams, Michelle M., Ganeshkumar, Sornakala, Gunewardena, Sumedha, Graham, Amanda, Nothnick, Warren B., Chennathukuzhi, Vargheese M.
Publicado 2022

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

por Faber, Erik B., Sun, Luxin, Tang, Jian, Roberts, Emily, Ganeshkumar, Sornakala, Wang, Nan, Rasmussen, Damien, Majumdar, Abir, Hirsch, Laura E., John, Kristen, Yang, An, Khalid, Hira, Hawkinson, Jon E., Levinson, Nicholas M., Chennathukuzhi, Vargheese, Harki, Daniel A., Schönbrunn, Ernst, Georg, Gunda I.
Publicado 2023